Clinical Research Directory
Browse clinical research sites, groups, and studies.
Primary Cervical Cancer Screening by Self-sampling HPV Test
Sponsor: Peking University People's Hospital
Summary
Cervical cancer seriously threatens women's health and HPV infection is the main cause of cervical cancer. Traditionally, Cervical cancer screening is based on cervical exfoliated cell samples collected by health care provider, which is labor consuming and the coverage and compliance are both relatively low in some areas. Non-invasive hrHPV self-sampling test appears to be more acceptable and may improve the HPV screening coverage. This study aims to evaluate the clinical performance of a newly developed urine/vaginal self-sampling hrHPV test in Cervical cancer screening.
Key Details
Gender
FEMALE
Age Range
21 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
17875
Start Date
2022-11-19
Completion Date
2027-08-31
Last Updated
2023-12-21
Healthy Volunteers
Yes
Conditions
Locations (6)
Peking University People's Hospital
Beijing, Beijing Municipality, China
Henan Cancer Hospital
Zhengzhou, Henan, China
The Third Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Hunan Provincial Maternal and Child Health Care Hospital
Changsha, Hunan, China
Chengdu Women's and Children's Central Hospital
Chengdu, Sichuan, China
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, Zhejiang, China